Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT
A series of organometallic compds. of general formula [(arene)M(PTA)nXm]Y (arene = η6-C10H14, η-C5Me5); (M = Ru(II), Os(II), Rh(III) and Ir(III); X = Cl, mPTA; Y = OTf, PF6) have been screened for their cytotoxicity and ability to inhibit cathepsin B in vitro, in comparison to the antimetastatic compd. NAMI-A. The Ru and Os analogs and NAMI-A showed similar enzyme inhibition properties (with IC50 values in the low μM range), whereas the Rh(iii) and Ir(iii) compds. were inactive. To build up a rational for the obsd. differences, DFT calcns. of the metal complexes adducts with N-acetyl-l-cysteine-N'-methylamide, a mimic for the Cys residue in the cathepsin B active site, were performed to provide insights into binding thermodn. in soln. Initial structure-activity relationships have been defined with the calcd. binding energies of the M-S bonds correlating well with the obsd. inhibition properties of the compds.
Cite this item
Casini, A., Edafe, F., Erlandsson, M., Gonsalvi, L., Ciancetta, A., Re, N., Ienco, A., Messori, L., Peruzzini, M., & Dyson, P. J. (2010). Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT. Dalton Transactions, 39(23), 5556–5563. https://doi.org/10.1039/c003218b
Click Copy to copy the citation, or select the text manually.
WOS:000278965700019
2010
39
23
5556
5563
REVIEWED
EPFL